---
figid: PMC7956519__cancers-13-00984-g002
figtitle: Main non-canonical signaling pathways activated by JAK2V617F in Ph-negative
  MPNs
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC7956519
filename: cancers-13-00984-g002.jpg
figlink: pmc/articles/PMC7956519/figure/cancers-13-00984-f002/
number: F2
caption: Main non-canonical signaling pathways activated by JAK2V617F in Ph-negative
  MPNs. In PV patients, JAK2V617F (depicted in red) activates the adhesion receptor
  Lu/BCAM through the RAP1-AKT signaling pathway, making their erythrocytes more adhesive.
  JAK2V617F has also been described to promote aberrant signaling in the nucleus,
  where it prevents the binding of heterochromatin protein 1 alpha (HP1α) and inhibits
  the methylation of histones via protein arginine methyltransferase 5 (PRMT5) impairment.
  MPN patients with JAK2V617F also seem to be insensitive to the anti-inflammatory
  cytokine IL-10, increasing TNF-α production through Toll-Like Receptor (TLR) signaling.
papertitle: A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative
  Neoplasms.
reftext: Ana Guijarro-Hernández, et al. Cancers (Basel). 2021 Mar;13(5):984.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9729987
figid_alias: PMC7956519__F2
figtype: Figure
redirect_from: /figures/PMC7956519__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7956519__cancers-13-00984-g002.html
  '@type': Dataset
  description: Main non-canonical signaling pathways activated by JAK2V617F in Ph-negative
    MPNs. In PV patients, JAK2V617F (depicted in red) activates the adhesion receptor
    Lu/BCAM through the RAP1-AKT signaling pathway, making their erythrocytes more
    adhesive. JAK2V617F has also been described to promote aberrant signaling in the
    nucleus, where it prevents the binding of heterochromatin protein 1 alpha (HP1α)
    and inhibits the methylation of histones via protein arginine methyltransferase
    5 (PRMT5) impairment. MPN patients with JAK2V617F also seem to be insensitive
    to the anti-inflammatory cytokine IL-10, increasing TNF-α production through Toll-Like
    Receptor (TLR) signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL10
  - BCAM
  - BCAT2
  - EPOR
  - MPL
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - CSF2RA
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - AKT1
  - AKT2
  - AKT3
  - JAK2
  - TIRAP
  - MYD88
  - IRAK1
  - TRAF6
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAPK8
  - MAPK9
  - MAPK10
  - PRMT5
  - ATF2
  - GDNF
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - TNF
  - CBX5
  - il10
  - bcam
  - epor
  - mpl
  - terf2ip
  - jak2b
  - tirap
  - myd88
  - traf6
  - mapk8b
  - prmt5
  - atf2
  - tnfb
  - Lu
---
